Yüklüyor......
Treatment of Refractory Anemia with Ring Sideroblasts Associated with Marked Thrombocytosis with Lenalidomide in a Patient Testing Negative for 5q Deletion and JAK2 V617F and MPL W515K/L Mutations
Refractory anemia with ring sideroblasts associated with marked thrombocytosis (RARS-T) is a hematologic malignancy that often results in transfusion dependency and a hypercoagulable state. This rare disease currently lacks formal guidelines for treatment; however, various case reports have demonstr...
Kaydedildi:
| Yayımlandı: | Hematol Rep |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
PAGEPress Publications, Pavia, Italy
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5136742/ https://ncbi.nlm.nih.gov/pubmed/27994837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2016.6592 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|